Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.

Market Analysis and Insights: Global Personalized Cancer Vaccines Market

Personalized Cancer Vaccines Market

The global Personalized Cancer Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Cancer Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Cancer Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Cancer Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Cancer Vaccines market.

Personalized Cancer Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Cancer Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

By Type

By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Prostate Cancer
Cervical Cancer
Glioblastoma
Others

By Mechanism of Action Type

Tumor-associated antigens (TAAs)
Tumor-specific antigens (TSAs)
Somatic Mutations in Cancer Pharmacogenomics
Pharmacogenomics towards Genomic Polymorphism

By Application

Hospitals
Homecare
Specialty Clinics
Others

By Region

North America
US.
Canada
Europe
Germany
France
UK.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company

Advaxis Inc
Personalis
Hoffmann-La Roche Ltd
BioNtech
Celldex
CureVac AG
Genetech
Genocea
Gritstone Oncology
ISA Pharmaceuticals
Merck
Moderna Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Lung Cancer

1.2.3 Breast Cancer

1.2.4 Colorectal Cancer

1.2.5 Leukemia

1.2.6 Prostate Cancer

1.2.7 Cervical Cancer

1.2.8 Glioblastoma

1.2.9 Others

1.3 Market by Application

1.3.1 Global Personalized Cancer Vaccines Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Hospitals

1.3.3 Homecare

1.3.4 Specialty Clinics

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Personalized Cancer Vaccines Market Perspective (2016-2027)

2.2 Personalized Cancer Vaccines Growth Trends by Regions

2.2.1 Personalized Cancer Vaccines Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Personalized Cancer Vaccines Historic Market Share by Regions (2016-2021)

2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027)

2.3 Personalized Cancer Vaccines Industry Dynamic

2.3.1 Personalized Cancer Vaccines Market Trends

2.3.2 Personalized Cancer Vaccines Market Drivers

2.3.3 Personalized Cancer Vaccines Market Challenges

2.3.4 Personalized Cancer Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Personalized Cancer Vaccines Players by Revenue

3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2016-2021)

3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2016-2021)

3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue

3.4 Global Personalized Cancer Vaccines Market Concentration Ratio

3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2020

3.5 Personalized Cancer Vaccines Key Players Head office and Area Served

3.6 Key Players Personalized Cancer Vaccines Product Solution and Service

3.7 Date of Enter into Personalized Cancer Vaccines Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cancer Vaccines Breakdown Data by Type

4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2016-2021)

4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027)

5 Personalized Cancer Vaccines Breakdown Data by Application

5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2016-2021)

5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Personalized Cancer Vaccines Market Size (2016-2027)

6.2 North America Personalized Cancer Vaccines Market Size by Type

6.2.1 North America Personalized Cancer Vaccines Market Size by Type (2016-2021)

6.2.2 North America Personalized Cancer Vaccines Market Size by Type (2022-2027)

6.2.3 North America Personalized Cancer Vaccines Market Size by Type (2016-2027)

6.3 North America Personalized Cancer Vaccines Market Size by Application

6.3.1 North America Personalized Cancer Vaccines Market Size by Application (2016-2021)

6.3.2 North America Personalized Cancer Vaccines Market Size by Application (2022-2027)

6.3.3 North America Personalized Cancer Vaccines Market Size by Application (2016-2027)

6.4 North America Personalized Cancer Vaccines Market Size by Country

6.4.1 North America Personalized Cancer Vaccines Market Size by Country (2016-2021)

6.4.2 North America Personalized Cancer Vaccines Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Personalized Cancer Vaccines Market Size (2016-2027)

7.2 Europe Personalized Cancer Vaccines Market Size by Type

7.2.1 Europe Personalized Cancer Vaccines Market Size by Type (2016-2021)

7.2.2 Europe Personalized Cancer Vaccines Market Size by Type (2022-2027)

7.2.3 Europe Personalized Cancer Vaccines Market Size by Type (2016-2027)

7.3 Europe Personalized Cancer Vaccines Market Size by Application

7.3.1 Europe Personalized Cancer Vaccines Market Size by Application (2016-2021)

7.3.2 Europe Personalized Cancer Vaccines Market Size by Application (2022-2027)

7.3.3 Europe Personalized Cancer Vaccines Market Size by Application (2016-2027)

7.4 Europe Personalized Cancer Vaccines Market Size by Country

7.4.1 Europe Personalized Cancer Vaccines Market Size by Country (2016-2021)

7.4.2 Europe Personalized Cancer Vaccines Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8 Asia-Pacific

8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2016-2027)

8.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type

8.2.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2027)

8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application

8.3.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2027)

8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region

8.4.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Personalized Cancer Vaccines Market Size (2016-2027)

9.2 Latin America Personalized Cancer Vaccines Market Size by Type

9.2.1 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021)

9.2.2 Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027)

9.2.3 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2027)

9.3 Latin America Personalized Cancer Vaccines Market Size by Application

9.3.1 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021)

9.3.2 Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027)

9.3.3 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2027)

9.4 Latin America Personalized Cancer Vaccines Market Size by Country

9.4.1 Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021)

9.4.2 Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2016-2027)

10.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type

10.2.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2027)

10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application

10.3.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2027)

10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country

10.4.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Advaxis Inc

11.1.1 Advaxis Inc Company Details

11.1.2 Advaxis Inc Business Overview

11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction

11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.1.5 Advaxis Inc Recent Development

11.2 Personalis

11.2.1 Personalis Company Details

11.2.2 Personalis Business Overview

11.2.3 Personalis Personalized Cancer Vaccines Introduction

11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.2.5 Personalis Recent Development

11.3 Hoffmann-La Roche Ltd

11.3.1 Hoffmann-La Roche Ltd Company Details

11.3.2 Hoffmann-La Roche Ltd Business Overview

11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction

11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.3.5 Hoffmann-La Roche Ltd Recent Development

11.4 BioNtech

11.4.1 BioNtech Company Details

11.4.2 BioNtech Business Overview

11.4.3 BioNtech Personalized Cancer Vaccines Introduction

11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.4.5 BioNtech Recent Development

11.5 Celldex

11.5.1 Celldex Company Details

11.5.2 Celldex Business Overview

11.5.3 Celldex Personalized Cancer Vaccines Introduction

11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.5.5 Celldex Recent Development

11.6 CureVac AG

11.6.1 CureVac AG Company Details

11.6.2 CureVac AG Business Overview

11.6.3 CureVac AG Personalized Cancer Vaccines Introduction

11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.6.5 CureVac AG Recent Development

11.7 Genetech

11.7.1 Genetech Company Details

11.7.2 Genetech Business Overview

11.7.3 Genetech Personalized Cancer Vaccines Introduction

11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.7.5 Genetech Recent Development

11.8 Genocea

11.8.1 Genocea Company Details

11.8.2 Genocea Business Overview

11.8.3 Genocea Personalized Cancer Vaccines Introduction

11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.8.5 Genocea Recent Development

11.9 Gritstone Oncology

11.9.1 Gritstone Oncology Company Details

11.9.2 Gritstone Oncology Business Overview

11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction

11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.9.5 Gritstone Oncology Recent Development

11.10 ISA Pharmaceuticals

11.10.1 ISA Pharmaceuticals Company Details

11.10.2 ISA Pharmaceuticals Business Overview

11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction

11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.10.5 ISA Pharmaceuticals Recent Development

11.11 Merck

11.11.1 Merck Company Details

11.11.2 Merck Business Overview

11.11.3 Merck Personalized Cancer Vaccines Introduction

11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.11.5 Merck Recent Development

11.12 Moderna Therapeutics

11.12.1 Moderna Therapeutics Company Details

11.12.2 Moderna Therapeutics Business Overview

11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction

11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021)

11.12.5 Moderna Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Advaxis Inc

Personalis

Hoffmann-La Roche Ltd

List of Tables

Table 1. Global Personalized Cancer Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

Table 2. Key Players of Lung Cancer

Table 3. Key Players of Breast Cancer

Table 4. Key Players of Colorectal Cancer

Table 5. Key Players of Leukemia

Table 6. Key Players of Prostate Cancer

Table 7. Key Players of Cervical Cancer

Table 8. Key Players of Glioblastoma

Table 9. Key Players of Others

Table 10. Global Personalized Cancer Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Table 11. Global Personalized Cancer Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Table 12. Global Personalized Cancer Vaccines Market Size by Regions (2016-2021) & (US$ Million)

Table 13. Global Personalized Cancer Vaccines Market Share by Regions (2016-2021)

Table 14. Global Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)

Table 15. Global Personalized Cancer Vaccines Market Share by Regions (2022-2027)

Table 16. Personalized Cancer Vaccines Market Trends

Table 17. Personalized Cancer Vaccines Market Drivers

Table 18. Personalized Cancer Vaccines Market Challenges

Table 19. Personalized Cancer Vaccines Market Restraints

Table 20. Global Personalized Cancer Vaccines Revenue by Players (2016-2021) & (US$ Million)

Table 21. Global Personalized Cancer Vaccines Market Share by Players (2016-2021)

Table 22. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Vaccines as of 2020)

Table 23. Ranking of Global Top Personalized Cancer Vaccines Companies by Revenue (US$ Million) in 2020

Table 24. Global 5 Largest Players Market Share by Personalized Cancer Vaccines Revenue (CR5 and HHI) & (2016-2021)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Personalized Cancer Vaccines Product Solution and Service

Table 27. Date of Enter into Personalized Cancer Vaccines Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 30. Global Personalized Cancer Vaccines Revenue Market Share by Type (2016-2021)

Table 31. Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 32. Global Personalized Cancer Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)

Table 33. Global Personalized Cancer Vaccines Market Size Share by Application (2016-2021) & (US$ Million)

Table 34. Global Personalized Cancer Vaccines Revenue Market Share by Application (2016-2021)

Table 35. Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 36. Global Personalized Cancer Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)

Table 37. North America Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 38. North America Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)

Table 39. North America Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 40. North America Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)

Table 41. North America Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million)

Table 42. North America Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million)

Table 43. Europe Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 44. Europe Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)

Table 45. Europe Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 46. Europe Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)

Table 47. Europe Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million)

Table 48. Europe Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million)

Table 49. Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 50. Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)

Table 51. Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 52. Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)

Table 53. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021) & (US$ Million)

Table 54. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027) & (US$ Million)

Table 55. Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 56. Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)

Table 57. Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 58. Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)

Table 59. Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million)

Table 60. Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million)

Table 61. Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 62. Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)

Table 63. Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 64. Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)

Table 65. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million)

Table 66. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million)

Table 67. Advaxis Inc Company Details

Table 68. Advaxis Inc Business Overview

Table 69. Advaxis Inc Personalized Cancer Vaccines Product

Table 70. Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 71. Advaxis Inc Recent Development

Table 72. Personalis Company Details

Table 73. Personalis Business Overview

Table 74. Personalis Personalized Cancer Vaccines Product

Table 75. Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 76. Personalis Recent Development

Table 77. Hoffmann-La Roche Ltd Company Details

Table 78. Hoffmann-La Roche Ltd Business Overview

Table 79. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product

Table 80. Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 81. Hoffmann-La Roche Ltd Recent Development

Table 82. BioNtech Company Details

Table 83. BioNtech Business Overview

Table 84. BioNtech Personalized Cancer Vaccines Product

Table 85. BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 86. BioNtech Recent Development

Table 87. Celldex Company Details

Table 88. Celldex Business Overview

Table 89. Celldex Personalized Cancer Vaccines Product

Table 90. Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 91. Celldex Recent Development

Table 92. CureVac AG Company Details

Table 93. CureVac AG Business Overview

Table 94. CureVac AG Personalized Cancer Vaccines Product

Table 95. CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 96. CureVac AG Recent Development

Table 97. Genetech Company Details

Table 98. Genetech Business Overview

Table 99. Genetech Personalized Cancer Vaccines Product

Table 100. Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 101. Genetech Recent Development

Table 102. Genocea Company Details

Table 103. Genocea Business Overview

Table 104. Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 105. Genocea Recent Development

Table 106. Gritstone Oncology Company Details

Table 107. Gritstone Oncology Business Overview

Table 108. Gritstone Oncology Personalized Cancer Vaccines Product

Table 109. Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 110. Gritstone Oncology Recent Development

Table 111. ISA Pharmaceuticals Company Details

Table 112. ISA Pharmaceuticals Business Overview

Table 113. ISA Pharmaceuticals Personalized Cancer Vaccines Product

Table 114. ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 115. ISA Pharmaceuticals Recent Development

Table 116. Merck Company Details

Table 117. Merck Business Overview

Table 118. Merck Personalized Cancer Vaccines Product

Table 119. Merck Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 120. Merck Recent Development

Table 121. Moderna Therapeutics Company Details

Table 122. Moderna Therapeutics Business Overview

Table 123. Moderna Therapeutics Personalized Cancer Vaccines Product

Table 124. Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)

Table 125. Moderna Therapeutics Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Personalized Cancer Vaccines Market Share by Type: 2020 VS 2027

Figure 2. Lung Cancer Features

Figure 3. Breast Cancer Features

Figure 4. Colorectal Cancer Features

Figure 5. Leukemia Features

Figure 6. Prostate Cancer Features

Figure 7. Cervical Cancer Features

Figure 8. Glioblastoma Features

Figure 9. Others Features

Figure 10. Global Personalized Cancer Vaccines Market Share by Application: 2020 VS 2027

Figure 11. Hospitals Case Studies

Figure 12. Homecare Case Studies

Figure 13. Specialty Clinics Case Studies

Figure 14. Others Case Studies

Figure 15. Personalized Cancer Vaccines Report Years Considered

Figure 16. Global Personalized Cancer Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027

Figure 17. Global Personalized Cancer Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027

Figure 18. Global Personalized Cancer Vaccines Market Share by Regions: 2020 VS 2027

Figure 19. Global Personalized Cancer Vaccines Market Share by Regions (2022-2027)

Figure 20. Global Personalized Cancer Vaccines Market Share by Players in 2020

Figure 21. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Vaccines as of 2020

Figure 22. The Top 10 and 5 Players Market Share by Personalized Cancer Vaccines Revenue in 2020

Figure 23. Global Personalized Cancer Vaccines Revenue Market Share by Type (2016-2021)

Figure 24. Global Personalized Cancer Vaccines Revenue Market Share by Type (2022-2027)

Figure 25. North America Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 26. North America Personalized Cancer Vaccines Market Share by Type (2016-2027)

Figure 27. North America Personalized Cancer Vaccines Market Share by Application (2016-2027)

Figure 28. North America Personalized Cancer Vaccines Market Share by Country (2016-2027)

Figure 29. United States Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 30. Canada Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 31. Europe Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 32. Europe Personalized Cancer Vaccines Market Share by Type (2016-2027)

Figure 33. Europe Personalized Cancer Vaccines Market Share by Application (2016-2027)

Figure 34. Europe Personalized Cancer Vaccines Market Share by Country (2016-2027)

Figure 35. Germany Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 36. France Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 37. U.K. Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 38. Italy Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 39. Russia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 40. Nordic Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 41. Asia-Pacific Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 42. Asia-Pacific Personalized Cancer Vaccines Market Share by Type (2016-2027)

Figure 43. Asia-Pacific Personalized Cancer Vaccines Market Share by Application (2016-2027)

Figure 44. Asia-Pacific Personalized Cancer Vaccines Market Share by Region (2016-2027)

Figure 45. China Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 46. Japan Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 47. South Korea Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 48. Southeast Asia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 49. India Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 50. Australia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 51. Latin America Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 52. Latin America Personalized Cancer Vaccines Market Share by Type (2016-2027)

Figure 53. Latin America Personalized Cancer Vaccines Market Share by Application (2016-2027)

Figure 54. Latin America Personalized Cancer Vaccines Market Share by Country (2016-2027)

Figure 55. Mexico Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 56. Brazil Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 57. Middle East & Africa Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 58. Middle East & Africa Personalized Cancer Vaccines Market Share by Type (2016-2027)

Figure 59. Middle East & Africa Personalized Cancer Vaccines Market Share by Application (2016-2027)

Figure 60. Middle East & Africa Personalized Cancer Vaccines Market Share by Country (2016-2027)

Figure 61. Turkey Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 62. Saudi Arabia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 63. UAE Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 64. Advaxis Inc Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 65. Personalis Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 66. Hoffmann-La Roche Ltd Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 67. BioNtech Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 68. Celldex Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 69. CureVac AG Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 70. Genetech Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 71. Genocea Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 72. Gritstone Oncology Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 73. ISA Pharmaceuticals Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 74. Merck Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 75. Moderna Therapeutics Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Personalized Cancer Vaccines Market Size, Status and Forecast 2021-2027

Published Date: July 2021

Report Code: QYRE-Auto-13T6071

Global Personalized Cancer Vaccines Market Size, Status and Forecast 2021-2027

FEATURED COMPANIES

Personalized Cancer Vaccines Market

By Type

By Mechanism of Action Type

By Application

By Region

By Company

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User